Meaning and medication in the care of treatment-resistant patients

American Journal of Psychotherapy

Volumn 56, Issue 3, 2002, Pages 322-337

  Mintz, David ^a  

^a AUSTEN RIGGS CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

DOCTOR PATIENT RELATION; DRUG EFFECT; HUMAN; MENTAL DISEASE; PATIENT COMPLIANCE; PSYCHODYNAMICS; PSYCHOPHARMACOLOGY; REVIEW;

EID: 0036424762     PISSN: 00029564     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psychotherapy.2002.56.3.322     Document Type: Review

References (39)

1. Gabbard G (1992).Psychodynamic psychiatry in the "decade of the brain." The American Journal of Psychiatry, 149, 991-998.
2. Detre T, McDonald MC (1997).Managed care and the future of psychiatry. Archives of General Psychiatry; 54, 201-204.
3. Lieberman JA, Rush AJ (1996). Redefining the role of psychiatry in medicine. The American Journal of Psychiatry, 153, 1388-1397.
4. Schreter RK (1997). Coping with the crisis in psychiatric training. Psychiatry, 60, 51-59.
5. Mohl PC et al. (1990). Psychotherapy training for the psychiatrist of the future. The American Journal of Psychiatry, 147, 7-13.
6. Wallerstein RS (1991). The future of psychotherapy. Bulletin of the Menninger Clinic, 55, 421-443.
7. Bluestone H et al. (1999). Should clinical training in long-term psychodynamic psychotherapy be mandatory in residency training? Journal of Psychotherapy Practice and Research, 8, 162-169.
8. Kuhn T (1962). The Structure of Scientific Revolutions, Chicago: University of Chicago Press.
9. Rush AJ, Treverdi MH (1995). Treating depression to remission. Psychiatric Annals, 25, 704-709.
10. Sheitman BB, Lieberman JA (1998). The natural history and pathophysiology of treatment- resistant schizophrenia, Journal of Psychiatric Research, 32, 143-150.
11. Heresco-Levy U et al. (1999). Treatment-resistant schizophrenia and staff rejection, Schizophrenia Bulletin, 25, 457-465.
12. Khan A et al. (2000). Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the Food and Drug Administration database. Archives of General Psychiatry, 57, 311-317.
13. Antonuccio DO et al. (1999). Raising questions about antidepressants. Psychotherapy and Psychosomatics, 68, 3-14.
14. Kirsch I, Sapirstein G (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. In Prevention and Treatment, Vol.1. [add info]
15. Greenberg RP, Fisher S (1989). Examining antidepressant effectiveness: Findings, ambiguities, and some vexing puzzles. In R.P. Greenberg & S. Fisher (Eds.), The Limits of Biological Treatments for Psychological Distress: Comparisons with Psychotherapy and Placebo. Hillsdale, NJ: Erlbaum.
16. Greenberg RP, Fisher S (1997). Mood mending medicines: Probing drug, psychotherapy, and placebo solutions, In R.P. Greenberg & S. Fisher (Eds.), From Placebo to Panacea. New York, NY: John Wiley & Sons.
17. Smith ML et al. (1980). The benefits of psychotherapy. Baltimore, MD: Johns Hopkins University Press.
18. Rapaport MH et al. (2000). Is placebo response the same as drug response in panic disorder. American Journal of Psychiatry, 157, 1014-1016.
19. Shear MK et al. (1995). Pattern of placebo response in panic disorder. Psychopharmacology Bulletin, 31, 273-278.
20. Keck PE et al. (2000). Placebo effect in randomized, controlled studies of acute bipolar mania and depression. Biological Psychiatry, 47, 748-755.
21. Quitkin FM (1999). Placebos, drug effects, and study design: A clinician's guide. American Journal of Psychiatry, 156, 829-836.
22. Cramer JA, Rosenheck R (1998). Compliance with medication regimens for mental and physical disorders. Psychiatric Services, 49, 196-201.
23. Boudes P (1998). Drug compliance in therapeutic trials: A review. Controlled Clinical Trials, 19, 257-268.
24. Nevins DB (1977).Adverse response to neuroleptics in schizophrenia, International Journal of Psychoanalytic Psychotherapy, 6, 227-241.
25. Brockman R (1990).Medication and transference in psychoanalytically oriented psychotherapy of the borderline patient. Psychiatric Clinics of North America, 13, 287-295.
26. Mintz D (2000). Non-pharmacologic effects of sildenafil. Psychiatric Services, 51,674 51, 674-675.
27. Ellison J (2000). Enhancing compliance in the pharmacotherapy relationship. In A. Tasman, M.B. Riba & K.R. Silk (Eds.), The Doctor-Patient Relationship in Pharmacotherapy. New York: The Guilford Press.
28. Beitman BD et al (1994).Patient stage of change predicts outcome in a panic disorder medication trial. Anxiety, 1, 64-69.
29. Fields HL, Price DD (1997). Toward a neurobiology of placebo analgesia. In A. Harrington, (Ed.), The Placebo Effect: An Interdisciplinary Exploration. Cambridge, MA: Harvard University Press.
30. Spiro H (1997). Clinical reflections on the placebo phenomenon, In A. Harrington, (Ed.), The Placebo Effect: An Interdisciplinary Exploration. Cambridge, MA: Harvard University Press.
31. Freud S (1912/1958). The dynamics of transference. In The Standard Edition, Vol.12. London: Hogarth Press.
32. Cannon WB (1942). Voodoo death. American Anthropologist, 44,169-181.
33. Price DD, Fields HL (1997). The contribution of desire and expectation to placebo analgesia: Implications for new research strategies, In A. Harrington, (Ed.), The Placebo Effect: An Interdisciplinary Exploration. Cambridge, MA: Harvard University Press.
34. Hahn RA (1997). The nocebo phenomenon: Scope and foundations, In A. Harrington, (Ed.), The Placebo Effect: An Interdisciplinary Exploration. Cambridge, MA: Harvard University Press.
35. Mintz D (1991). The distancing function of language in medicine. The Journal of Medical Humanities, 13, 223-233.
36. Docherty JP et al. (1977).Psychotherapy and pharmacotherapy: Conceptual lenses. American Journal of Psychiatry, 134, 529-33.
37. Gutheil TG (1982). The psychology of psychopharmacology, Bulletin of the Menninger Clinic, 46, 321-330.
38. Nevins DB (1990).Psychoanalytic perspectives on the use of medications for mental illness Bulletin of the Menninger Clinic, 54, 323-339.
39. Jibson MD (2000). Transference and countertransference. In A. Tasman, M.B. Riba, & K.R Silk (Eds.), The Doctor-Patient Relationship in Pharmacotherapy. New York: The Guilford Press.